The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.5M data for 737K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

19 articles for D Gordon


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Steroids. 2. Synthesis of C-18 functionalized steroids via the Smith-Hughes route.EBI
TBA
Tetrahydroisoquinoline 1-carboxamides as growth hormone secretagogues.EBI
Bristol-Myers Squibb Pharmaceutical Research Institute
(D)-2-tert-Butoxycarbonylamino-5,5-difluoro-5-phenyl-pentanoic acid: synthesis and incorporation into the growth hormone secretagogues.EBI
Bristol Myers Squibb
Tetrazole based amides as growth hormone secretagogues.EBI
Bristol-Myers Squibb Research and Development
Design and synthesis of tetrazole-based growth hormone secretagogue: the SAR studies of the O-benzyl serine side chain.EBI
Bristol Myers Squibb
Design of selective, ATP-competitive inhibitors of Akt.EBI
Pfizer
Design and optimisation of selective serotonin re-uptake inhibitors with high synthetic accessibility: part 2.EBI
Pfizer
Design and optimization of selective serotonin re-uptake inhibitors with high synthetic accessibility. Part 1.EBI
Pfizer
The design and discovery of novel amide CCR5 antagonists.EBI
Pfizer
PROTACs Targeting BRM (SMARCA2) Afford Selective In Vivo Degradation over BRG1 (SMARCA4) and Are Active in BRG1 Mutant Xenograft Tumor Models.EBI
Arvinas LLC
Discovery of BMS-986235/LAR-1219: A Potent Formyl Peptide Receptor 2 (FPR2) Selective Agonist for the Prevention of Heart Failure.EBI
Kyorin Pharmaceutical
A novel series of highly potent benzimidazole-based microsomal triglyceride transfer protein inhibitors.EBI
The Bristol-Myers Squibb Pharmaceutical Research Institute
Identification of substituted benzothiazole sulfones as potent and selective inhibitors of endothelial lipase.EBI
Bristol-Myers Squibb
Sulfonylated Benzothiazoles as Inhibitors of Endothelial Lipase.EBI
Bristol-Myers Squibb
Discovery and synthesis of tetrahydropyrimidinedione-4-carboxamides as endothelial lipase inhibitors.EBI
Bristol-Myers Squibb
Identification of Reversible Small Molecule Inhibitors of Endothelial Lipase (EL) That Demonstrate HDL-C Increase In Vivo.EBI
TBA
Biphenyl Acid Derivatives as APJ Receptor Agonists.EBI
Bristol-Myers Squibb
METTL3 INHIBITORY COMPOUNDSBDB
Storm Therapeutics
6,7-dihydropyrido[2,1-A]phthalazin-2-ones for the treatment and prophylaxis of hepatitis B virus infectionBDB
Hoffmann-La Roche